home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Allchem Pharma

SHARESHARESHARE
At Allchem Pharma our expertise lies in the sourcing and supply of raw materials and ingredients to manufacturers of pharmaceutical, nutraceutical, veterinarian, medical and supplement products.
SHARESHARESHARE

RELATED NEWS


Grifols, a global healthcare company and one of world's top producers of plasma-derived medicines, today announced it has executed purchase arrangements with the South Korean-based GC Pharma (Group) whereby Grifols will acquire the Montreal-based plasma fractionation facility and two purification facilities, along with 11 U.S.-based plasma collection centers for a total amount of US$460 million.

The transaction is part of Grifols' sustainable global growth strategy to expa...

PR NEWSWIRE
READ MORE

Turbulence and turmoil in the pharmaceutical industry will only prove to be temporary in spite of President-elect Donald Trump's vow to clamp down on drug pricing, according to Royal Philips' chief executive. Frans Van Houten, chief executive of the medical equipment and technology firm, described the current situation in the pharmaceutical industry as "uncertain" however he remained confident the negative sentiment surrounding healthcare stocks would be reversed in time....

READ MORE

AstraZeneca is preparing an assault on the growing market for GLP-1-class diabetes drugs with a dual action molecule that the firm hopes could be as effective as a gastric band – and may even have potential in the lucrative market to treat “fatty liver” disease nicknamed NASH. In an interview with pharmaphorum, Ludovic Helfgott, AstraZeneca’s vice-president for cardiovascular, renal and metabolism, highlighted encouraging mid-stage data from MEDI0382, a potential first-in...

READ MORE

AstraZeneca’s Daxas (roflumilast) has been knocked back in draft guidance by the National Institute for Health and Care Excellence (NICE), rejected by the regulator as a treatment for chronic obstructive pulmonary disease (COPD). The treatment was rejected on the basis of cost-effectiveness; AstraZeneca calculated the drug’s price per quality-adjusted life-year (QALY) gained at £18,774, but NICE placed the figure at £71,365 by utilising different data, leaving the committee no choice but to b...

READ MORE

The US Food and Drug Administration (FDA) has announced an update on its method recommendation of testing for NDMA in ranitidine medication products. The ingredient is a probable human carcinogen. A previous method published by the FDA for testing angiotensin II receptor blockers (ARBs) for nitrosamine impurities has been utilised by a third-party laboratory to test ranitidine products. However, this uses high temperatures which results in ranitidine generating NDMA. Therefore, the FDA has recom...

READ MORE

People in every corner of Montana rely on prescription drugs to treat illnesses and conditions ranging from mild to severe. Our most vulnerable neighbors need access to these drugs even more than the rest of us. Senior citizens, people with chronic conditions, and sick children all use prescriptions to provide them comfort from pain and, in the case of those with the worst sicknesses, keep them alive....

READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...